Fast-growing pancreatic cancer in a patient with MEN1
Author Information
Author(s): Jens Waldmann, Nils Habbe, Volker Fendrich, Emily P. Slater, Peter H. Kann, Matthias Rothmund, Peter Langer
Primary Institution: University Hospital Giessen and Marburg
Hypothesis
The study investigates the growth rate of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 (MEN1).
Conclusion
Fast-growing neuroendocrine tumors are rare in patients with MEN1, and screening intervals should be reduced to 6 months for early diagnosis.
Supporting Evidence
- The patient developed a fast-growing neuroendocrine carcinoma within 15 months of surgery.
- Regular screening programs are intended to detect malignant tumors at the earliest stage possible.
- The study suggests reducing follow-up intervals to 6 months for patients with rapidly progressive disease.
Takeaway
This study shows that some tumors in patients with MEN1 can grow quickly, so doctors should check them more often to catch problems early.
Methodology
The study followed 45 patients with MEN1 through an annual screening program, monitoring for tumor development.
Limitations
The study is based on a single case report, which may not be generalizable to all MEN1 patients.
Participant Demographics
The patient was a 37-year-old man with MEN1 and a family history of the condition.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website